ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
9.32
+0.26 (2.87%)
Mar 9, 2026, 1:02 PM EDT - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $921.27 million as of March 9, 2026. Its market cap has decreased by -19.53% in one year.
Market Cap
921.27M
Enterprise Value
746.96M
1-Year Change
-19.53%
Ranking
Category
Stock Price
$9.32
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $921.27M, an increase of 62.12%. That is a compound annual growth rate of 15.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 895.57M | -22.23% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SELLAS Life Sciences Group | 941.66M |
| Cullinan Therapeutics | 929.86M |
| Valneva SE | 920.15M |
| Maravai LifeSciences Holdings | 912.59M |
| Fortrea Holdings | 898.54M |
| SpyGlass Pharma | 888.91M |
| uniQure | 888.90M |
| Arbutus Biopharma | 871.23M |